The Initial Use of the Home Medication Experience Questionnaire (HOME-Q) in Community-Based Pharmacy

The Initial Use of the Home Medication Experience Questionnaire (HOME-Q) in Community-Based Pharmacy

The Home Medication Experience Questionnaire (HOME-Q) was developed to systematically gather information on the medication experience of patients. The objectives of this study were to (1) assess the frequencies of medication experience issues for a sample of patients and (2) report pharmacist recomm...

Full description

Bibliographic Details
Main Authors:	Matthew J Witry PharmD, PhD, Kassi Pham B.A., Brahmendra Viyyuri PharmD, William Doucette PhD, Korey Kennelty PharmD, MS, PhD
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-12-01
Series:	Journal of Patient Experience
Online Access:	https://doi.org/10.1177/2374373520916015

Similar Items

Older adult perceptions of a self-reported medication risk questionnaire: A focus group study.
by: Matthew J. Witry PharmD, Graduate Student, et al.
Published: (2011-01-01)

Inviting Scholarship in Leadership in Pharmacy
by: Kristin K. Janke, Ph.D., et al.
Published: (2010-01-01)

Drug-induced hypersensitivity reactions in a Lebanese outpatient population: A decade-long retrospective analysis (2012-2021)
by: Joelle Dagher, PharmD, PhD, et al.
Published: (2024-02-01)

Defining Levels of Learning for Strengths Development Programs in Pharmacy
by: Kristin K. Janke, Ph.D., et al.
Published: (2010-01-01)

Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements
by: Richard J. Silvia, PharmD, BCPP, et al.
Published: (2022-04-01)

Perceptions of clinical pharmacy specialists' contributions in mental health clinical teams
by: Chris Gillespie, PhD, et al.
Published: (2022-01-01)

International Market Access Strategies for Artificial Intelligence–Based Medical Devices: Can We Standardize the Process to Faster Patient Access?
by: Line Farah, Pharm D, et al.
Published: (2023-09-01)

Coping, resilience, and emotional well-being in pharmacy students during the COVID-19 pandemic
by: Andrea V. Fuentes, PharmD, et al.
Published: (2021-09-01)

Adverse childhood experiences among California student pharmacists
by: Shawn R. Smith, PharmD, APh, et al.
Published: (2024-02-01)

Impact of holding home stimulant(s) on agitation in a child and adolescent inpatient psychiatric population
by: Anupha M. Mathew, PharmD, BCPS, et al.
Published: (2023-03-01)

Consumer perception, knowledge, and uses of cannabidiol
by: Nguyen Cambrey PharmD, et al.
Published: (2023-10-01)

An evaluation of clinical decision support tools for Patient Health Questionnaire-9 administration
by: Naweid Maten, PharmD, et al.
Published: (2021-09-01)

Potentially Inappropriate Medication Prescribing in Older Adults According to EU(7)-Potentially Inappropriate Medication List: A Nationwide Study in Portugal
by: Daniela A. Rodrigues, MSc, et al.
Published: (2022-01-01)

Characterization of inpatient care for patients admitted to a psychiatric hospital with a home opioid prescription
by: Kei Takamura, PharmD, BCPS, BCPP, et al.
Published: (2023-03-01)

Learning From Consultations Conducted by Community Pharmacists in Northern Ireland for Nonprescription Sildenafil: A Qualitative Study Using the Theoretical Domains Framework
by: Rineke Gordijn, PharmD, et al.
Published: (2021-12-01)

Publication rates and characteristics of PGY2 psychiatric pharmacy resident research projects
by: Dayton L. Antley, PharmD, BCPS, BCPP, et al.
Published: (2023-01-01)

Impact of marketing to improve patient access to care and clinic utilization for clinical pharmacy specialists
by: Nora Bairagdar, PharmD, BCPS, et al.
Published: (2023-03-01)

Antipsychotics in child and adolescent patients with major depressive disorder: A retrospective analysis of prescribing patterns
by: Danielle Dauchot, PharmD, et al.
Published: (2024-02-01)

Contraceptive Use and Missed Opportunities for Family Planning Discussions in Women Living with Human Immunodeficiency Virus at an HIV Clinic
by: Ashley Winters PharmD, et al.
Published: (2022-12-01)

Offering a combined resident research training program and pharmacy student elective may help improve resident publication rates
by: Brown Geoffrey PharmD, et al.
Published: (2023-08-01)

Quetiapine and olanzapine misuse prevalence in a US general population sample
by: Kirk E Evoy, PharmD, BCACP, BC-ADM, CTTS, et al.
Published: (2023-04-01)

Comparison of inpatient psychiatric medication management in gender diverse youth with cisgender peers
by: Carrillo Nina PharmD, et al.
Published: (2023-08-01)

Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
by: Still Daniel PharmD, BCPP, et al.
Published: (2023-06-01)

Increasing access to psychiatric care during the COVID-19 pandemic through mental health clinical pharmacy specialist services
by: Vickery P. Brittany PharmD, BCPS, BCPP, CPP, et al.
Published: (2023-08-01)

Individualized Dosing of Children’s Liquid Medications in the Community Pharmacy Setting: A Survey of Parents and Guardians
by: Lingxiao Zhai, MS, et al.
Published: (2013-01-01)

Impact of COVID-19 quarantines on clozapine-induced constipation: Experience of utilizing a clozapine-induced constipation protocol at a state forensic psychiatric facility
by: Bridgette M. Gleisner, PharmD, et al.
Published: (2024-02-01)

Therapeutic Lifestyle Strategies Taught in U.S. Pharmacy Schools
by: Thomas L. Lenz, PharmD, MA, et al.
Published: (2007-10-01)

Association of Valproic Acid Use With Post-Myocardial Infarction Heart Failure Development: A Meta-Analysis of Two Retrospective Case–Control Studies
by: Joseph D. English PharmD, et al.
Published: (2022-11-01)

Cefepime Daily Exposure and the Associated Impact on the Change in Sequential Organ Failure Assessment Scores and Vasopressors Requirement in Critically Ill Patients Using Repeated-Measures Mixed-Effect Modeling
by: Mohammad H. Alshaer, PharmD, PhD, et al.
Published: (2023-11-01)

Best practice model for outpatient psychiatric pharmacy practice, part 2: Confirmation of the attribute statements
by: Kelly C. Lee, PharmD, MAS, BCPP, et al.
Published: (2022-04-01)

Impact of traditional versus nontraditional initiation dosing schedule of paliperidone palmitate on 30-day readmission and safety
by: Erika Kim, PharmD, BCPP, et al.
Published: (2023-12-01)

Effectiveness of Anise Oil for Treatment of Mild to Moderate Depression in Patients With Irritable Bowel Syndrome
by: Maryam Mosaffa-Jahromi PharmD, PhD, et al.
Published: (2017-01-01)

Data Missingness Reporting and Use of Methods to Address It in Critical Care Cohort Studies
by: Ting Ting Wu, PharmD, et al.
Published: (2023-11-01)

Overview of Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Targeted Therapy and Supportive Care for Lung Cancer
by: Kaleem Anwar, PharmD, et al.
Published: (2023-02-01)

Knowledge, Attitude and Practice Related to Chemotherapy Among Cancer Patients
by: Muzna Suhail MPhil, et al.
Published: (2024-04-01)

Assessment of Performance, Interpretability, and Explainability in Artificial Intelligence–Based Health Technologies: What Healthcare Stakeholders Need to Know
by: Line Farah, PharmD, et al.
Published: (2023-06-01)

Alternatives to Hydrocortisone for Hemodynamic Support in Septic Shock Management Due to Medication Shortage
by: Mohammed Aldhaeefi, PharmD, et al.
Published: (2023-07-01)

Assessment of Anticoagulant Initiation in Patients With New-Onset Atrial Fibrillation During Emergency Department Visit
by: Ehsan Habeeb PharmD, BCPS, et al.
Published: (2023-05-01)

Closing the gap: Raising medical professionals' transgender awareness and medical proficiency through pharmacist-led education
by: Ardsley P. Congdon III, PharmD, BCPS, BCPP, et al.
Published: (2021-01-01)

Evaluation of Latex Immunoturbidimetric Assay Thresholds and HIT in Cardiothoracic Surgery
by: Jessica Hernandez PharmD, BCCP, et al.
Published: (2023-10-01)